La compra pública d'innovació: instrument de col·laboració per a nous escenaris
Fuente:
Zenodo
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Recurso digital |
| Sprache: | Katalanisch |
| Veröffentlicht: |
Zenodo
2018
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866902081464434688 |
|---|---|
| author | Maspons, Ramon Alessandrello, Rossana |
| author_facet | Maspons, Ramon Alessandrello, Rossana |
| contents | <p class="MsoNormal"><span>Healthcare innovation is defined as the successful transformation of knowledge into new or improved products, services, and processes that generate measurable value within health systems. Technological innovation, in particular, plays a critical role due to its impact on efficiency, quality of care, and sustainability. Innovation in healthcare is driven by three main sources: market pressures, technological advances, and end-user needs, especially those of patients and healthcare professionals. However, the healthcare sector presents structural barriers to innovation, including regulatory constraints, fragmented reimbursement systems, interoperability limitations, and the complexity of public healthcare organizations. The adoption of innovations also depends on cost-effectiveness analyses and the long-term sustainability of interventions. Hospitals increasingly implement innovation management structures to accelerate the translation of research outcomes into clinical applications and marketable solutions. Public procurement of innovation has emerged as a strategic policy instrument to stimulate demand-driven technological development and strengthen collaboration between healthcare providers, industry, and research institutions. In this context, models such as pre-commercial procurement and innovation partnerships facilitate the development and deployment of advanced healthcare technologies. Furthermore, new public-private partnership frameworks and risk-sharing agreements are becoming essential to support precision medicine, digital health, and sustainable healthcare transformation.</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20068480 |
| institution | Zenodo |
| language | cat |
| publishDate | 2018 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | La compra pública d'innovació: instrument de col·laboració per a nous escenaris Maspons, Ramon Alessandrello, Rossana Pre-commercial procurement (PCP) Innovation Procurement (PPI) Innovation adoption <p class="MsoNormal"><span>Healthcare innovation is defined as the successful transformation of knowledge into new or improved products, services, and processes that generate measurable value within health systems. Technological innovation, in particular, plays a critical role due to its impact on efficiency, quality of care, and sustainability. Innovation in healthcare is driven by three main sources: market pressures, technological advances, and end-user needs, especially those of patients and healthcare professionals. However, the healthcare sector presents structural barriers to innovation, including regulatory constraints, fragmented reimbursement systems, interoperability limitations, and the complexity of public healthcare organizations. The adoption of innovations also depends on cost-effectiveness analyses and the long-term sustainability of interventions. Hospitals increasingly implement innovation management structures to accelerate the translation of research outcomes into clinical applications and marketable solutions. Public procurement of innovation has emerged as a strategic policy instrument to stimulate demand-driven technological development and strengthen collaboration between healthcare providers, industry, and research institutions. In this context, models such as pre-commercial procurement and innovation partnerships facilitate the development and deployment of advanced healthcare technologies. Furthermore, new public-private partnership frameworks and risk-sharing agreements are becoming essential to support precision medicine, digital health, and sustainable healthcare transformation.</span></p> |
| title | La compra pública d'innovació: instrument de col·laboració per a nous escenaris |
| topic | Pre-commercial procurement (PCP) Innovation Procurement (PPI) Innovation adoption |
| url | https://doi.org/10.5281/zenodo.20068480 |